CLH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Clean Harbors is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock looks fundamentally favored by Wall Street and hedge funds, but the current setup is mixed: price is sitting near pivot resistance, momentum is only moderate, options sentiment is mildly bullish, and the latest price action does not show a strong breakout. If the investor is impatient and wants an immediate entry, this is more of a hold than an outright buy at the current level.
CLH is trading at 286.78, just above the pivot at 284.65 and below first resistance at 292.87. MACD histogram is positive and expanding, which supports short-term bullish momentum, but RSI at 53.15 is neutral and moving averages are converging, showing the trend is not strongly directional yet. The setup suggests consolidation with a slight bullish bias, but not a high-conviction entry for a long-term beginner right now.
["Hedge funds are buying strongly, with buying up 883.21% over the last quarter.", "Recent analyst coverage is mostly positive, with several firms raising targets and multiple Buy/Outperform ratings.", "Stifel resumed coverage with a Buy rating and a $337 target, citing secular tailwinds and Clean Harbors' leading market position.", "Citi upgraded the stock to Buy with a $346 target, citing stronger U.S. chemicals production and more hazardous waste disposal opportunities.", "SwingMax issued an entry signal on 2026-06-03, which supports a swing-trade bullish bias.", "The stock trend model suggests a positive probability over the next week."]
["No news in the recent week, so there is no fresh catalyst driving the shares right now.", "The stock is trading below several bullish analyst targets, but price action has not yet confirmed a strong breakout.", "Insiders are neutral, so there is no supportive insider buying signal.", "Congress trading data shows 2 sales and 0 purchases over the last 90 days, which leans cautious.", "The latest price forecast from the stock trend model is slightly negative over the next month."]
Financial snapshot data was not available due to an error, so a full quarterly financial read is not possible here. Based on the analyst commentary, the most recent quarter appears to have been strong enough for multiple firms to raise price targets and models after a Q1 beat-and-raise. That implies improving growth trends in the latest reported quarter, likely the Q1 2026 season, but exact revenue and EPS figures were not provided.
Analyst sentiment is clearly positive overall. Recent actions include Stifel initiating/resuming Buy at $337, Citi upgrading to Buy at $346, TD Cowen at Buy with $335, Oppenheimer at Outperform with $316, Truist at Buy with $325, Baird at Outperform with $350, while UBS and Barclays remain more cautious with Neutral/Equal Weight ratings. The pros view is that CLH has secular demand tailwinds, market leadership, and upside to guidance; the cons view is that some of the strength may be cyclical or already priced in, and a few firms remain neutral because of valuation or sustainability concerns.
